The Duke Clinical Research Institute (DCRI) is now assuming a greater role in national efforts to deliver effective, personalized therapies to patients more broadly and rapidly. The institute now serves as the Clinical Data Coordinating Center for the National Institutes of Health (NIH)-sponsored Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (AMP® BGTC) clinical trials. The role was announced at the AMP BGTC session during the American Society of Gene & Cell Therapy Annual Meeting in May 2026.

ARPA-H award supports nationwide effort to build next-generation artificial intelligence tools designed to enable an integrated, holistic cardiovascular care platform that provides real-time guidance that patients and care teams can act on.

Faculty and teams from the Duke Clinical Research Institute (DCRI) contributed to a broad range of scientific and educational sessions at the 2026 European Society of Cardiology (ESC) Congress, held Aug. 28-31 in Munich. Their work was featured across presentations, guideline discussions, chair and discussant roles, and several of the congress's highly anticipated Hot Line studies.

The Duke Clinical Research Institute (DCRI) recently welcomed 33 students to the 2026 Summer Training in Academic Research (STAR) Program — the largest cohort since the program’s launched in 2012. STAR is a research training program for high school, undergraduate, and medical students that combines virtual and in-person instruction in research methodology and scientific writing.